Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received Idecabtagene Vicleucel : A Single Center Study​

Authors

• Nilesh Kalariya, The University of Texas MD Anderson Cancer Center
• Christopher Ferreri, The University of Texas MD Anderson Cancer Center
• Christen Dillard, The University of Texas MD Anderson Cancer Center
• Misha Hawkins, The University of Texas MD Anderson Cancer Center
• Elisabet Manasanch, The University of Texas MD Anderson Cancer Center
• Hans Lee, The University of Texas MD Anderson Cancer Center
• Donna Weber, The University of Texas MD Anderson Cancer Center
• Sheeba Thomas PhD, The University of Texas MD Anderson Cancer Center
• Raphael Steiner, The University of Texas MD Anderson Cancer Center
• Chitra Hosing, The University of Texas MD Anderson Cancer Center
• Muzaffar H. Qazilbash, The University of Texas MD Anderson Cancer Center
• Uday Popat, The University of Texas MD Anderson Cancer Center
• Robert Orlowski, The University of Texas MD Anderson Cancer Center
• Michelle Hildebrandt, The University of Texas MD Anderson Cancer Center
• Krina Patel, The University of Texas MD Anderson Cancer Center

Files

Description

Nilesh Kalariya pictured.

Publication Date

2022

Recommended Citation

Kalariya, Nilesh; Ferreri, Christopher; Dillard, Christen; Hawkins, Misha; Manasanch, Elisabet; Lee, Hans; Weber, Donna; Thomas, Sheeba PhD; Steiner, Raphael; Hosing, Chitra; Qazilbash, Muzaffar H.; Popat, Uday; Orlowski, Robert; Hildebrandt, Michelle; and Patel, Krina, "Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received Idecabtagene Vicleucel : A Single Center Study​" (2022). APRN Week 2022. 14.
https://openworks.mdanderson.org/aprn-week-22/14